Uncategorised - European Medical Journal

Urinary Extracellular Vesicles Improve Prostate Cancer Detection

A machine learning model using urinary extracellular vesicle physical parameters demonstrated strong diagnostic performance for early prostate cancer detection.

Month in pharma news, explained

Month in pharma news, explained – May 2026

From a potential breakthrough in pancreatic cancer to fresh Ebola concerns and more FDA leadership turmoil, discover the most-read stories.

Trial points to breakthrough in cancer metastasis prevention

A phase 2a study has revealed encouraging early evidence for cancer metastasis prevention, with fewer metastatic recurrences and no metastasis-related deaths in treated patients.

EuroPCR 2026 Interview: Nicolas Dumonteil

Each year, we begin building the next edition of EuroPCR around September, always starting from the needs of the community…

Immune Side Effects Linked to Better Survival in Biliary Tract Cancer

Imaging-detected immune-related adverse events may help predict improved survival in patients with advanced biliary tract cancer receiving durvalumab-based chemotherapy.

Female patient discussing ADHD reproductive health symptoms with a clinician

ADHD Linked to Greater Reproductive Health Challenges

ADHD may intensify reproductive health challenges across menstruation, pregnancy, and menopause, new Irish cross-sectional data suggest.

Age-Related and Disease-Specific Upper Cervical Cord Atrophy in MS

Spinal cord atrophy has been consistently reported in multiple sclerosis (MS), and represents a key predictor of clinical disability…

Review of the American Academy of Neurology (AAN) Annual Meeting 2026

Across plenary presentations, late-breaking science sessions, poster discussions, and educational forums, several recurring themes emerged…

Unlocking the Future of Paediatric Myotonia

Stay tuned for an interactive video on the Lupin Neurosciences Sponsored symposium from EPNS 2025 titled Unlocking the…

Updates in Multiple Sclerosis: AAN Annual Meeting 2026

Aaron Miller, Icahn School of Medicine at Mount Sinai, New York, USA, reviewed the latest 2024 McDonald Criteria, noting that it was developed…